Browsing by Author "Garcia, Juliana"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- Antimicrobial, Antibiofilm, and Antioxidant Properties of Boletus edulis and Neoboletus luridiformis Against Multidrug-Resistant ESKAPE PathogensPublication . Garcia, Juliana; Rodrigues, Francisca; Castro, Flávia; Aires, Alfredo; Marques, Guilhermina; Saavedra, Maria JoséMultidrug-resistant ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) has become the most recurrent global cause of skin and soft-tissue infections, belonging to the WHO priority pathogens list. Successful therapy remains challenging and entails the assessment of novel and successful antibiotics. In this study, mushrooms are considered a valuable and unique source of natural antimicrobial compounds. Therefore, this study aimed to evaluate the antimicrobial and antibiofilm properties of Boletus edulis (B. edulis) and Neoboletus luridiformis (N. luridiformis) aqueous and methanolic extracts against ESKAPE isolates from clinical wound infections. Disk diffusion and microdilution methods were used to assess the antimicrobial activity. Phytochemical characterization was achieved by analysis of total phenols, orthodiphenols content, and antioxidant activity as well as by high-performance liquid chromatography-diode array detector (HPLC-DAD). Human foreskin fibroblasts-1 (HFF-1) cell viability was performed by the MTT assay. Aqueous and methanolic extracts of B. edulis and N. luridiformis showed antimicrobial and antibiofilm properties against multidrug-resistant bacteria, although with different efficacy rates. The results showed that there is a convincing relation between the content of phenolic compounds, antioxidant activity, and antimicrobial activity suggesting that the presence of phenolic compounds may explain the biological effects. HPLC analysis revealed high levels of protocatechuic acid, homogentisic acid, pyrogallol, gallic acid, p-catechin, and dihydroxybenzoic acid in the aqueous extract of B. edulis, explaining the highest antimicrobial and antibiofilm properties. Importantly, the mushrooms extracts were non-cytotoxic at all the tested concentrations. Overall, the tested mushrooms extracts are good candidates to further explore its use in the prevention of wound infection, particularly by multidrug-resistant pathogens
- Bioactive polysaccharides from medicinal mushrooms: A review on their isolation, structural characteristics and antitumor activityPublication . Garcia, Juliana; Rodrigues, Francisca; Saavedra, Maria José; Nunes, Fernando M.; Marques, GuilherminaMushrooms either alone or in combination with conventional cancer treatment have been enhanced the efficacy of chemotherapy and radiotherapy improving the patients' quality of life. These therapy effects have been attributed to polysaccharides; the most potent compounds found in the fungi kingdom. Due to their wide range of biological activity and the backbone of glucose residues linked by β-(1 → 3)-glycosidic bonds, often with attached side-chain glucose residues joined by β-(1 → 6) linkages, the mushroom's polysaccharides, particularly the β-glucans, are the most versatile metabolites. Lentinan, D-fraction, and schizophyllan from Lentinula edodes, Grifola frondosa, and Schizophyllum commune, respectively are well-known β-glucans, however, the precise immunomodulation and anticancer mechanisms of action remain to be uncovered. According to several studies, β-glucan can interact with certain receptors on macrophages and dendritic cells, such as dectin-1 and TLRs, producing different cytokines and, in turn, indirectly activating other immune cells including T and B cells. Moreover, recent findings have proved that β-glucans have a direct cytotoxic effect on cancer cells suppressing proliferation and enhancing apoptosis possibly via multiple pathways such as PI3K/Akt/mTOR, NF-κB-, ERK-, ERα-, caspase- and p53-dependent pathways. Indeed, this study intends to provide information on the lentinan, D-fraction, and schizophyllan by examining the extraction procedures, chemical composition, and immunostimulatory and antitumoral biological activities. Future research directions should be directed toward improving the validity and reliability of randomized trials to confirm the potential role of β-glucans on the immune system and as anticancer therapy.
- Eco-friendly insights on kiwiberry leaves valorization through in-vitro and in-vivo studiesPublication . Silva, Ana Margarida; Garcia, Juliana; Dall'Acqua, Stefano; Costa, Paulo; Delerue-Matos, Cristina; Rodrigues, FranciscaOn the last decade, the demand for novel active skin ingredients based on sustainable principles arise as a trend. These new concerns transformed the consumer preferences, which are not actually solved by the industry portfolio. Regulatory aspects establish guidelines to assess the safety and efficacy of new cosmetic ingredients, being this step imperative to introduce a new ingredient on the market. Our last studies reported the richness of Actinidia arguta (kiwiberry) leaves in bioactive compounds with potential skin applications, but further studies are necessary to validate this extract. Therefore, the current study aimed to screen the hydroalcoholic extract of A. arguta leaves regarding elastase and hyaluronidase inhibition, achieving excellent results (65.62 ± 2.09% and 54.64 ± 4.17%, respectively). The cell viability was assessed in keratinocytes and fibroblasts (0.1–1000 μg/mL), ensuring the absence of cytotoxic effects. Afterwards, 3D models, namely a skin (EpiSkin™) and an ocular (SkinEthic™ HCE, respectively) model, were used to estimate the irritant potential. The viability achieved in both models after exposure to the extract was, respectively, 55.18 ± 10.60% and 101.15 ± 5.96%. The IL-1α released for the skin and ocular models were, respectively, 0 pg/mL and 35.60 ± 2.61 pg/mL, being the extract classified as non-irritant for both models. Lastly, in-vivo studies performed through a patch test in 10 human volunteers proved the absence of allergic or irritative reactions. Overall, the results attained highlighted that the hydroalcoholic kiwiberry leaves extract is an excellent cosmetic ingredient, being not irritant to skin application
- From soil to cosmetic industry: Validation of a new cosmetic ingredient extracted from chestnut shellsPublication . Pinto, Diana; de la Luz Cádiz-Gurrea, María; Garcia, Juliana; Saavedra, Maria José; Freitas, Vitor; Costa, Paulo; Sarmento, Bruno; Delerue-Matos, Cristina; Rodrigues, FranciscaSustainability arises as a challenge in the last decades and the cosmetic field is not an exception. The search for new cosmetic active principles extracted from food byproducts through eco-innovative technologies has emerged as a novel concept. However, the European Regulation is very restrictive and different assays should be performed to guarantee the products' efficacy and safety. Considering a multidisciplinary approach, this paper aims to compare chestnut shell extracts prepared by three different green techniques – Subcritical Water Extraction (SWE), Ultrasound-Assisted Extraction (UAE) and Supercritical Fluids Extraction (SFE) – regarding antimicrobial activity, hyaluronidase and elastase inhibitory activities, in-vitro cytotoxicity on dermal cells (HaCaT and HFF-1) and skin permeation (using Franz cells coupled to human skin). The best extract was tested on skin and ocular 3D models and through an in-vivo patch test to evaluate its irritancy and safety. The results demonstrated the antimicrobial properties of the extracts (particularly against Staphylococcus aureus) as well as the capacity to inhibit the hyaluronidase (IC50 = 0.76–54.36 mg/mL) and elastase (33.56–82.70% at 0.4 mg/mL) activities. Regarding in-vitro cell assays, UAE and SWE extracts revealed the best outcomes. Between 0.1 and 100 μg/mL, none of the extracts conducted to a decrease of cell viability in both cell lines (HaCaT and HFF-1). The ex-vivo assay proved that SWE extract led to a higher polyphenol's permeation (1061.6 μg/g dw), being selected for further assays. Ellagic acid was the major polyphenol that permeated the human skin (732.1–847.0 μg/g dw). The 3D skin and ocular models evidenced absence of irritation by SWE extract, without decreasing cell viability and releasing IL-1α. Finally, an in-vivo patch test confirmed the absence of irritation in humans based on the acute irritation index of 0.50 achieved 24 h after the patch removal. To the best of our knowledge, this is the first study that validated by in-vitro and in-vivo assays, and in accordance with the European Regulation 1223/2009, a new cosmetic ingredient extracted from chestnut shells.
- Honey as an Adjuvant in the Treatment of COVID-19 Infection: A ReviewPublication . Soares, Sónia; Bornet, Mélina; Grosso, Clara; Ramalhosa, Maria João; Gouvinhas, Irene; Garcia, Juliana; Rodrigues, Francisca; Delerue-Matos, CristinaSince ancestor times, honey has been used to promote human health due to its medicinal, and nutritious properties, mainly due to bioactive compounds present, such as phenolic compounds. The emergence of COVID-19, caused by the SARS-CoV-2 virus, led to the pursuit of solutions for the treatment of symptoms and/or disease. Honey has proven to be effective against viral infections, principally due to its potential antioxidant and anti-inflammatory activities that attenuate oxidative damage induced by pathogens, and by improving the immune system. Therefore, the aim of this review is to overview the abilities of honey to attenuate different COVID-19 symptoms, highlighting the mechanisms associated with these actions and relating the with the different bioactive compounds present. A brief, detailed approach to SARS-CoV-2 mechanism of action is first overviewed to allow readers a deep understanding. Additionally, the compounds and beneficial properties of honey, and its previously application in other similar diseases, are detailed in depth. Despite the already reported efficacy of honey against different viruses and their complications, further studies are urgently needed to explain the molecular mechanisms of activity against COVID-19 and, most importantly, clinical trials enrolling COVID-19 patients.